No announcement yet.

Homeopathic & Other Treatment of Human Papilloma Virus - HPV

  • Filter
  • Time
  • Show
Clear All
new posts

  • Homeopathic & Other Treatment of Human Papilloma Virus - HPV

    Homeopathic & Other Treatment of Human Papilloma Virus - HPV

    Alternative treatments should focus on creating
    health, improving the terrain of the body/immune
    system/vital force so that your own immune
    system/vital force will take care of the
    disturbance. Any illness shows that the immune
    system is compromised. Acupuncture, homeopathy,
    detoxification, balancing your body chemistry,
    improving nutrition - all ways that you can work
    to improve your health - the terrain - and the disease goes away.

    Homeopathy would treat you according to your
    total symptom picture including the HPV
    symptoms. It would be individualized to you and your symptom picture


    The concept of regularly cleansing or detoxifying
    the body is an ancient one. It has become even
    more important now with our daily exposure to
    toxins in our air and food. A toxic body cannot
    effectively absorb nutrients or eliminate waste
    and when we support the body to function
    optimally, we greatly enhance our feeling of
    wellbeing and can improve our overall health
    status. Common improvements seen by those who
    complete a detox program are increased energy and
    mental clarity, strengthened immune function,
    clearer skin and a decrease in GI discomfort.

    Immune Support
    Chronic infections such as bronchitis, pneumonia,
    recurrent yeast infections, recurrent urinary
    tract infections, chronic fatigue syndrome all
    point to a depressed and depleted immune
    system. The immune system needs to be
    strengthened and the body brought back into balance.

    Infections such as HPV, HSV I and II, Hepatitis
    C, can be treated with natural antiviral agents
    that also support the immune system instead of suppressing the symptoms.

    As far as prevention goes, a very high percentage
    of women are exposed to the HPV virus but why
    don’t all those women get abnormal pap
    smears? Dr. Nevels states that, “Pap smears do
    not always show to be abnormal due to the
    person’s diet, lifestyle, and environmental
    factors which are very important to consider. A
    diet consisting of vital nutrients keeps the body
    strong and disease resistant. Stress can be a
    trigger that will decrease the immune
    system. With a weakened immune system the HPV
    virus has a greater ability to change the
    cervix. Smoking is also a significant factor.”

    Naturopathic Medicine has innovative treatment
    options for women with HPV. Depending on
    severity & lifestyle of the patient, Dr. Nevels
    has an effective treatment protocol that involves
    applications of botanicals and zinc chloride to
    the cervix which helps to destroy abnormal cells
    along with vitamin therapy, and vitamin rich
    suppositories. Clinically, she has seen
    regression and reversal of abnormalities.
    Alternative Medicine

    A study of the clinical efficacy of green tea
    extracts (polyphenon E; poly E and
    (-)-epigallocatechin-3-gallate [EGCG]) delivered
    in a form of ointment or capsule in patients with
    human papilloma virus (HPV) infected cervical
    lesions. Fifty-one patients with cervical lesions
    (chronic cervicitis, mild dysplasia, moderate
    dysplasia and severe dysplasia) were divided into
    four groups, as compared with 39 untreated
    patients as a control. Poly E ointment was
    applied locally to 27 patients twice a week. For
    oral delivery, a 200 mg of poly E or EGCG capsule
    was taken orally every day for eight to 12 weeks.
    In the study, 20 out of 27 patients (74%) under
    poly E ointment therapy showed a response. Six
    out of eight patients under poly E ointment plus
    poly E capsule therapy (75%) showed a response,
    and three out of six patients (50%) under poly E
    capsule therapy showed a response. Six out of 10
    patients (60%) under EGCG capsule therapy showed a response. (34).

    Overall, a 69% response rate (35/ 51) was noted
    for treatment with green tea extracts, as
    compared with a 10% response rate (4/39) in
    untreated controls (P<0.05). Thus, the data
    collected here demonstrated that green tea
    extracts in a form of ointment and capsule are
    effective for treating cervical lesions,
    suggesting that green tea extracts can be a
    potential therapy regimen for patients with HPV
    infected cervical lesions. (34).

    Women who consume low amounts of foods rich in
    vitamin C, beta carotene and folic acid have a
    higher incidence of CIN and HPV (14). A diet rich
    in fruits, vegetables, whole grains and legumes
    (beans) will provide generous amounts of these nutrients.

    Antioxidants seem to reduce the risk of CIN (8)
    and cancer (21). Low levels of vitamin A (16),
    vitamin C (15,16) and vitamin E (2,13) are
    associated with a greater risk of CIN and
    possibly cervical cancer. The amount of
    antioxidants in a daily multivitamin are reasonable and safe.

    Copper levels tend to be higher in women with CIN
    (9) or gynecologic tumors (3). It may be wise to
    avoid taking copper supplements if dealing with CIN.

    Folic acid levels tend to be lower in women with
    dysplasia (7,10) and HPV (4). Folic acid may help
    prevent CIN but does not appear to eradicate
    existing CIN (24). Very high doses of folic acid
    have been used in treatment but the amounts
    present in a B-complex supplement or a daily
    multivitamin are reasonable for preventive purposes.

    Pyridoxine (B6) levels tend to be low in cervical
    cancer (20). It is interesting that birth control
    pills can lower B6 levels (1,17) and birth
    control pills also seem to be a risk factor for
    CIN (4,5) which can progress to cervical cancer
    if left untreated. Taking vitamin B6 in a daily
    multivitamin or B-complex supplement may be
    beneficial, particularly if using birth control pills.

    Riboflavin (B2) levels tend to be low in women
    with CIN (16). Riboflavin vaginal suppositories
    have actually been shown to cause regression of CIN (6).

    Selenium levels tend to be lower in women with
    cervical cancer (2). Selenium has been shown to
    reduce the incidence of experimentally induced
    cervical cancer in laboratory animals (12). A
    dose of 200 micrograms daily of selenium is
    reasonable and safe (18). This amount of selenium
    is often available in a daily multivitamin.

    Zinc levels tend to be lower in women with CIN
    (9) or gynecologic tumors (3). Taking 15 - 30
    milligrams of zinc daily in a multivitamin is reasonable.

    STD information and referrals to STD Clinics
    1-800-CDC-INFO (800-232-4636)
    TTY: 1-888-232-6348


    1. Bermond P: Therapy of side effects of oral
    contraceptive agents with vitamin B6. Acta Vitaminol Enzymol 1982;4(1-2):45-54.

    2. Bhuvarahamurthy V, Balasubramanian N &
    Govindasamy S: Effect of radiotherapy and
    chemoradiotherapy on circulating antioxidant
    system of human uterine cervical carcinoma. Mol
    Cell Biochem 1996 May 10;158 (1):17-23.

    3. Brandes JM, Lightman A, Drugan A et al: The
    diagnostic value of serum copper/zinc ratio in
    gynecological tumors. Acta Obstet Gynecol Scand 1983;62(3):225-9.

    4. Butterworth CE: Folate deficiency and cervical
    dysplasia. JAMA 1992;267:528-533.

    5. Castaneda-Iniguez MS, Toledo-Cisneros R &
    Aguilera-Delgadillo M: [Risk factors for
    cervico-uterine cancer in women in Zacatecas]
    Salud Publica Mex 1998 Jul-Aug;40(4):330-8.

    6. Chen RD: [Chemoprevention of cervical
    cancer--intervention study of cervical
    precancerous lesions by retinamide II and
    riboflavin] Chung Hua Chung Liu Tsa Chih 1993 Jul;15(4):272-4.

    7. Fowler BM, Giuliano AR, Piyathilake C et al:
    Hypomethylation in cervical tissue: is there a
    correlation with folate status? Cancer Epidemiol
    Biomarkers Prev 1998 Oct;7(10):901-6.

    8. Goodman MT, Kiviat N, McDuffie K et al:,,The
    association of plasma micronutrients with the
    risk of cervical dysplasia in Hawaii. Cancer
    Epidemiol Biomarkers Prev 1998 Jun;7(6):537-44.

    9. Grail A & Norval M: Copper and zinc levels in
    serum from patients with abnormalities of the
    uterine cervix. Acta Obstet Gynecol Scand 1986;65(5):443-7.

    10. Grio R, Piacentino R, Marchino GL et al:
    Antineoblastic activity of antioxidant vitamins:
    the role of folic acid in the prevention of
    cervical dysplasia. Panminerva Med 1993 Dec;35(4):193-6.

    11. Ho GY, Kadish AS, Burk RD, Basu J, Palan PR,
    Mikhail M, Romney SL: HPV 16 and cigarette
    smoking as risk factors for high-grade cervical
    intra-epithelial neoplasia. Int J Cancer 1998 Oct 29;78 (3):281-5.

    12. Hussain SP, Rao AR: Chemopreventive action of
    selenium on methylcholanthrene-induced
    carcinogenesis in the uterine cervix of mouse. Oncology 1992;49(3):237-40.

    13. Kwasniewska A, Charzewska J, Tukendorf A,
    Semczuk M: Dietary factors in women with
    dysplasia colli uteri associated with human
    papillomavirus infection. Nutr Cancer 1998;30(1):39-45.

    14. Kwasniewska A, Tukendorf A, Semczuk M:
    Content of alpha- tocopherol in blood serum of
    human Papillomavirus-infected women with cervical
    dysplasias. Nutr Cancer 1997;28(3):248-51.

    15. Liu T, Soong SJ, Alvarez RD et al: A
    longitudinal analysis of human papillomavirus 16
    infection, nutritional status, and cervical
    dysplasia progression. Cancer Epidemiol Biomarkers Prev 1995 Jun;4 (4):373-80.

    16. Liu T, Soong SJ, Wilson NP et al: A case
    control study of nutritional factors and cervical
    dysplasia. Cancer Epidemiol Biomarkers Prev 1993 Nov-Dec;2(6):525-30.

    17. Masse PG, van den Berg H, Duguay C et al:
    Early effect of a low dose (30 micrograms)
    ethinyl estradiol-containing Triphasil on vitamin
    B6 status. A follow-up study on six menstrual
    cycles. Int J Vitam Nutr Res 1996;66(1):46-54

    18. Patterson BH & Levander OA: Naturally
    occurring selenium compounds in cancer
    chemoprevention trials: a workshop summary.
    Cancer Epidemiol Biomarkers Prev 1997 Jan;6(1):63-9.

    19. Potischman N: Nutritional epidemiology of
    cervical neoplasia. J Nutr 1993 Feb;123(2 Suppl):424-9.

    20. Ramaswamy PG & Natarajan R: Vitamin B6 status
    in patients with cancer of the uterine cervix. Nutr Cancer 1984;6(3):176-80.

    21. Reddy BS: Micronutrients as chemopreventive
    agents. IARC Sci Publ 1996;(139):221-35.

    22. Roteli-Martins CM, Panetta K, Alves VA et al:
    Cigarette smoking and high-risk HPV DNA as
    predisposing factors for high-grade cervical
    intraepithelial neoplasia (CIN) in young
    Brazilian women. Acta Obstet Gynecol Scand 1998 Jul;77(6):678-82.

    23. Yoshikawa H, Nagata C, Noda K et al: Human
    papillomavirus infection and other risk factors
    for cervical intraepithelial neoplasia in Japan.
    Br J Cancer 1999 May;80(3-4):621-4.

    24. Zarcone R, Bellini P, Carfora E, et al. Folic
    acid and cervix dysplasia. Minerva Ginecol
    1996;48:397-400. alteration of glucose tolerance.

    25. Centers for Disease Control and Prevention,
    Division of STD Prevention. Prevention of genital
    HPV infection and sequelae: Report of an external
    consultants' meeting. December 1999.

    26. Centers for Disease Control and Prevention.
    Sexually transmitted diseases treatment
    guidelines 2002. Morbidity and Mortality Weekly Report 2002; 51(RR*6).

    27. Chu NR. Therapeutic vaccination for the
    treatment of mucosotropic human
    papillomavirus-associated disease. Expert Opinion
    on Biological Therapy 2003; 3(3):477*486.

    28. Ho GYF, Bierman R, Beardsley L, Chang CJ,
    Burk RD. Natural history of cervicovaginal
    papilloma virus infection in young women. N Engl J Med 1998;338:423-8.

    29. Koutsky LA, Kiviat NB. Genital human
    papillomavirus. In: K. Holmes, P. Sparling, P.
    Mardh et al (eds). Sexually Transmitted Diseases,
    3rd edition. New York: McGraw-Hill, 1999, p. 347-359.

    30. Kiviat NB, Koutsky LA, Paavonen J. Cervical
    neoplasia and other STD-related genital tract
    neoplasias. In: K. Holmes, P. Sparling, P. Mardh
    et al (eds). Sexually Transmitted Diseases, 3rd
    edition. New York: McGraw-Hill, 1999, p. 811-831.

    31. Myers ER, McCrory DC, Nanda K, Bastian L,
    Matchar DB. Mathematical model for the natural
    history of human papillomavirus infection and
    cervical carcinogenesis. American Journal of
    Epidemiology 2000; 151(12):1158-1171.

    32. Watts DH, Brunham RC. Sexually transmitted
    diseases, including HIV infection in pregnancy.
    In: K. Holmes, P. Sparling, P. Mardh et al (eds).
    Sexually Transmitted Diseases, 3rd edition. New
    York: McGraw-Hill, 1999, 1089-1132.

    33. Weinstock H, Berman S, Cates W. Sexually
    transmitted disease among American youth:
    Incidence and prevalence estimates, 2000.
    Perspectives on Sexual and Reproductive Health 2004; 36: 6-10..

    34. WS Ahn, J Yoo, SW Huh -Protective effects of
    green tea extracts on human cervical lesions -
    polyphenon E and EGCG - Brief Article, Alternative Medicine Review, Nov, 2003